Tech Company Financing Transactions
Massive Bio Funding Round
Massive Bio, based in New York, secured $9 million from private investors and Revo Capital.
Transaction Overview
Company Name
Announced On
6/2/2022
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Undisclosed
Investors
private investors (Lead Investor) (Kenan Turnacioglu)
Revo Capital (Lead Investor) (Cenk Bayrakdar)
Proceeds Purpose
This investment will enable the company to further scale its operations globally, invest in marketing, and launch additional non-status quo products in oncology clinical trial enrollment with its data-rich platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
90 West St. 12M
New York, NY 10006
USA
New York, NY 10006
USA
Phone
Website
Email Address
Overview
When you do, you're at the mercy of one institution and its limitations. You need a team that draws expertise from every possible place and person to give you the confidence you want in your treatment plan. This is what Massive Bio is all about. We founded Massive Bio because of our own personal experiences with loved ones battling cancer within the broken healthcare system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Selin Kurnaz
Chief Operating Officer
Cagatay Culcuoglu
Co-Founder
Arturo Loaiza-Bonilla
VP - Operations
Jo Victor
Browse more venture capital transactions:
Prev: 6/2/2022: SolarCycle venture capital transaction
Next: 6/2/2022: Devo venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs